Michael Palfreyman is a seasoned biopharmaceutical executive with extensive experience in research and development across various companies. Currently serving as the Chief Research & Development Officer at Cybin Inc. since December 2020, Michael also holds a role as Senior R&D Diligence at Torrey Pines Investment, where responsibilities include identifying and analyzing biotechnology and pharmaceutical products for investment purposes. Previous roles include Chief Scientific Officer at Amorsa Therapeutics, Inc., Senior Vice President of Drug Development at Aminex Therapeutics, and Chairman of the Board at Amakem Therapeutics, NV, specializing in targeted therapeutics. Michael's career spans several key positions in drug development and translational research, complemented by an academic background that includes a Ph.D. and D.Sc. in neurochemistry, along with a Bachelor of Pharmacy from the University of Nottingham.
This person is not in the org chart
This person is not in any teams
This person is not in any offices